EP Patent

EP2389933A1 — Controlled-Release Pregabalin Compositions

Assigned to Arven Ilac Sanayi ve Ticaret AS · Expires 2011-11-30 · 14y expired

What this patent protects

The present invention provides an orally-administrable controlled-release formulation, comprising pregabalin or a pharmaceutically acceptable salt of pregabalin and polycarbophil, as a controlled-release agent.

USPTO Abstract

The present invention provides an orally-administrable controlled-release formulation, comprising pregabalin or a pharmaceutically acceptable salt of pregabalin and polycarbophil, as a controlled-release agent.

Drugs covered by this patent

Patent Metadata

Patent number
EP2389933A1
Jurisdiction
EP
Classification
—
Expires
2011-11-30
Drug substance claim
No
Drug product claim
No
Assignee
Arven Ilac Sanayi ve Ticaret AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.